Results
|
|
9281.
|
|
|
|
9282.
|
[Response rates following neoadjuvant chemotherapy and breast preserving treatment in patients with locally advanced breast cancer]. [electronic resource] by
- Maráz, Róbert
- Boross, Gábor
- Svébis, Mihály
- Gyánti, Rita
- Vizhányó, Rita
- Hajnal, Lajos
- Markó, László
- Szucs, Miklós
- Ambrózay, Eva
- Lorincz, Margit
Producer: 20051215
In:
Magyar sebeszet vol. 58
Availability: No items available.
|
|
|
9283.
|
|
|
|
9284.
|
|
|
|
9285.
|
|
|
|
9286.
|
|
|
|
9287.
|
|
|
|
9288.
|
Keratinocyte growth factor is effective in the prevention of intestinal mucositis in patients with hematological malignancies treated with high-dose chemotherapy and autologous hematopoietic SCT: a video-capsule endoscopy study. [electronic resource] by
- Tsirigotis, P
- Triantafyllou, K
- Girkas, K
- Giannopoulou, V
- Ioannidou, E
- Chondropoulos, S
- Kalli, T
- Papaxoinis, G
- Pappa, V
- Papageorgiou, E
- Economopoulos, T
- Ladas, S D
- Dervenoulas, J
Producer: 20090818
In:
Bone marrow transplantation vol. 42
Availability: No items available.
|
|
|
9289.
|
Survival is poorer in patients with secondary core-binding factor acute myelogenous leukemia compared with de novo core-binding factor leukemia. [electronic resource] by
- Borthakur, Gautam
- Lin, E
- Jain, Nitin
- Estey, Elihu E
- Cortes, Jorge E
- O'Brien, Susan
- Faderl, Stefan
- Ravandi, Farhad
- Pierce, Sherry
- Kantarjian, Hagop
Producer: 20090817
In:
Cancer vol. 115
Availability: No items available.
|
|
|
9290.
|
[Effectiveness of remission induction with high-dose cytarabine for relapsed or refractory pediatric acute leukemia]. [electronic resource] by
- Horikoshi, Yasuo
- Kobayashi, Ryoji
- Endo, Mikiya
- Watanabe, Arata
- Kikuta, Atsushi
- Koike, Kazutoshi
- Hanada, Ryoji
- Hosoya, Ryota
- Ohara, Akira
- Ikuta, Koichiro
- Goto, Hiroaki
- Asami, Keiko
- Sugita, Kanji
- Horibe, Keizo
- Tsurusawa, Masahito
- Hori, Toshinari
- Hara, Junichi
- Nishimura, Shinichiro
- Nagatoshi, Yoshihisa
- Mugishima, Hideo
- Ohta, Shigeru
- Adachi, Souichi
- Tsukimoto, Ichiro
Producer: 20100518
In:
[Rinsho ketsueki] The Japanese journal of clinical hematology vol. 51
Availability: No items available.
|
|
|
9291.
|
|
|
|
9292.
|
|
|
|
9293.
|
|
|
|
9294.
|
|
|
|
9295.
|
Integrative nucleophosmin mutation-associated microRNA and gene expression pattern analysis identifies novel microRNA - target gene interactions in acute myeloid leukemia. [electronic resource] by
- Russ, Annika C
- Sander, Sandrine
- Lück, Sonja C
- Lang, Katharina M
- Bauer, Marion
- Rücker, Frank G
- Kestler, Hans A
- Schlenk, Richard F
- Döhner, Hartmut
- Holzmann, Karlheinz
- Döhner, Konstanze
- Bullinger, Lars
Producer: 20120404
In:
Haematologica vol. 96
Availability: No items available.
|
|
|
9296.
|
|
|
|
9297.
|
BEAM Conditioning Regimen Has Higher Toxicity Compared With High-Dose Melphalan for Salvage Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma. [electronic resource] by
- Veeraputhiran, Muthu
- Jain, Tania
- Deol, Abhinav
- Ayash, Lois
- Kim, Seongho
- Dyson, Gregory
- Bhutani, Divaya
- Lum, Lawrence G
- Ratanatharathorn, Voravit
- Uberti, Joseph P
- Abidi, Muneer H
Producer: 20160518
In:
Clinical lymphoma, myeloma & leukemia vol. 15
Availability: No items available.
|
|
|
9298.
|
A randomized comparison of daunorubicin 90 mg/m2 vs 60 mg/m2 in AML induction: results from the UK NCRI AML17 trial in 1206 patients. [electronic resource] by
- Burnett, Alan K
- Russell, Nigel H
- Hills, Robert K
- Kell, Jonathan
- Cavenagh, Jamie
- Kjeldsen, Lars
- McMullin, Mary-Frances
- Cahalin, Paul
- Dennis, Mike
- Friis, Lone
- Thomas, Ian F
- Milligan, Don
- Clark, Richard E
Producer: 20150826
In:
Blood vol. 125
Availability: No items available.
|
|
|
9299.
|
Oral Debio1143 (AT406), an antagonist of inhibitor of apoptosis proteins, combined with daunorubicin and cytarabine in patients with poor-risk acute myeloid leukemia--results of a phase I dose-escalation study. [electronic resource] by
- DiPersio, John F
- Erba, Harry P
- Larson, Richard A
- Luger, Selina M
- Tallman, Martin S
- Brill, Jeffrey M
- Vuagniaux, Gregoire
- Rouits, Elisabeth
- Sorensen, J Mel
- Zanna, Claudio
Producer: 20160324
In:
Clinical lymphoma, myeloma & leukemia vol. 15
Availability: No items available.
|
|
|
9300.
|
Phase II Trial of High-Dose Gemcitabine/Busulfan/Melphalan with Autologous Stem Cell Transplantation for Primary Refractory or Poor-Risk Relapsed Hodgkin Lymphoma. [electronic resource] by
- Nieto, Yago
- Thall, Peter F
- Ma, Junsheng
- Valdez, Benigno C
- Ahmed, Sairah
- Anderlini, Paolo
- Popat, Uday
- Jones, Roy B
- Shpall, Elizabeth J
- Hosing, Chitra
- Qazilbash, Muzaffar
- Kebriaei, Partow
- Alousi, Amin
- Timmons, Melissa
- Gulbis, Alison
- Myers, Alan
- Oki, Yasuhiro
- Fanale, Michelle
- Dabaja, Bouthaina
- Pinnix, Chelsea
- Milgrom, Sarah
- Champlin, Richard
- Andersson, Borje S
Producer: 20190710
In:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation vol. 24
Availability: No items available.
|